Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.92 USD | -4.58% | -12.56% | -12.95% |
14/05 | Poseida Therapeutics Q1 Net Loss Narrows, Revenue Rises | MT |
14/05 | Earnings Flash (PSTX) POSEIDA THERAPEUTICS Reports Q1 Revenue $28.1M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.95% | 30Cr | |
+10.52% | 12TCr | |
+12.15% | 11TCr | |
-4.81% | 2.47TCr | |
-2.33% | 2.2TCr | |
-6.03% | 1.93TCr | |
-13.64% | 1.76TCr | |
-40.50% | 1.73TCr | |
+6.02% | 1.4TCr | |
+30.56% | 1.21TCr |
- Stock Market
- Equities
- PSTX Stock
- News Poseida Therapeutics, Inc.
- Poseida Therapeutics : Promotes Johanna Mylet to Finance Chief